Kalaris Therapeutics (formerly AlloVir) — Post-IPO Equity
Kalaris Therapeutics (formerly AlloVir) raised $126.6M in a Post-IPO Equity round. View investors, financials, and press on Fsome.
Round Details
- Funded Company
- Kalaris Therapeutics (formerly AlloVir)
- Round Type
- Post-IPO Equity
- Amount Raised
- $126.6M
- Announced
- July 27, 2022
Canonical: https://fsome.com/funding/kalaris-therapeutics-formerly-allovir-post-ipo-equity-6176151 · For the full investor list, press references, and related rounds, please enable JavaScript.